Potassium carbonate

DB13977

small molecule approved

Deskripsi

Potassium carbonate (K2CO3) is a white salt, soluble in water (insoluble in ethanol) which forms a strongly alkaline solution. It can be made as the product of potassium hydroxide's absorbent reaction with carbon dioxide. It presents a large capacity to absorb moisture.

Struktur Molekul 2D

Berat 138.2055
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

289 Data
Ramipril The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Ramipril.
Fosinopril The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Fosinopril.
Trandolapril The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Trandolapril.
Benazepril The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Benazepril.
Enalapril The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Enalapril.
Moexipril The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Moexipril.
Lisinopril The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Lisinopril.
Perindopril The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Perindopril.
Quinapril The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Quinapril.
Omapatrilat The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Omapatrilat.
Rescinnamine The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Rescinnamine.
Captopril The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Captopril.
Cilazapril The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Cilazapril.
Spirapril The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Spirapril.
Temocapril The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Temocapril.
Enalaprilat The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Enalaprilat.
Imidapril The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Imidapril.
Zofenopril The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Zofenopril.
Delapril The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Delapril.
Benazeprilat The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Benazeprilat.
Fosinoprilat The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Fosinoprilat.
Ramiprilat The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Ramiprilat.
Trandolaprilat The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Trandolaprilat.
Moexiprilat The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Moexiprilat.
Perindoprilat The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Perindoprilat.
Quinaprilat The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Quinaprilat.
Cilazaprilat The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Cilazaprilat.
Triamterene The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Triamterene.
Spironolactone The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Spironolactone.
Amiloride The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Amiloride.
Eplerenone The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Eplerenone.
Canrenoic acid The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Canrenoic acid.
Canrenone The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Canrenone.
Valsartan Potassium carbonate may increase the hyperkalemic activities of Valsartan.
Olmesartan Potassium carbonate may increase the hyperkalemic activities of Olmesartan.
Losartan Potassium carbonate may increase the hyperkalemic activities of Losartan.
Candesartan cilexetil Potassium carbonate may increase the hyperkalemic activities of Candesartan cilexetil.
Eprosartan Potassium carbonate may increase the hyperkalemic activities of Eprosartan.
Telmisartan Potassium carbonate may increase the hyperkalemic activities of Telmisartan.
Irbesartan Potassium carbonate may increase the hyperkalemic activities of Irbesartan.
Forasartan Potassium carbonate may increase the hyperkalemic activities of Forasartan.
Saprisartan Potassium carbonate may increase the hyperkalemic activities of Saprisartan.
Tasosartan Potassium carbonate may increase the hyperkalemic activities of Tasosartan.
Saralasin Potassium carbonate may increase the hyperkalemic activities of Saralasin.
Azilsartan medoxomil Potassium carbonate may increase the hyperkalemic activities of Azilsartan medoxomil.
Fimasartan Potassium carbonate may increase the hyperkalemic activities of Fimasartan.
Candesartan Potassium carbonate may increase the hyperkalemic activities of Candesartan.
Cyclosporine Potassium carbonate may increase the hyperkalemic activities of Cyclosporine.
Icosapent Potassium carbonate may increase the hyperkalemic activities of Icosapent.
Esmolol Potassium carbonate may increase the hyperkalemic activities of Esmolol.
Betaxolol Potassium carbonate may increase the hyperkalemic activities of Betaxolol.
Fluconazole Potassium carbonate may increase the hyperkalemic activities of Fluconazole.
Succinylcholine Potassium carbonate may increase the hyperkalemic activities of Succinylcholine.
Mesalazine Potassium carbonate may increase the hyperkalemic activities of Mesalazine.
Metoprolol Potassium carbonate may increase the hyperkalemic activities of Metoprolol.
Isradipine Potassium carbonate may increase the hyperkalemic activities of Isradipine.
Indomethacin Potassium carbonate may increase the hyperkalemic activities of Indomethacin.
Atenolol Potassium carbonate may increase the hyperkalemic activities of Atenolol.
Diltiazem Potassium carbonate may increase the hyperkalemic activities of Diltiazem.
Trimethadione Potassium carbonate may increase the hyperkalemic activities of Trimethadione.
Timolol Potassium carbonate may increase the hyperkalemic activities of Timolol.
Amlodipine Potassium carbonate may increase the hyperkalemic activities of Amlodipine.
Digoxin Potassium carbonate may increase the hyperkalemic activities of Digoxin.
Nimodipine Potassium carbonate may increase the hyperkalemic activities of Nimodipine.
Nisoldipine Potassium carbonate may increase the hyperkalemic activities of Nisoldipine.
Ardeparin Potassium carbonate may increase the hyperkalemic activities of Ardeparin.
Trimethoprim Potassium carbonate may increase the hyperkalemic activities of Trimethoprim.
Nabumetone Potassium carbonate may increase the hyperkalemic activities of Nabumetone.
Ketorolac Potassium carbonate may increase the hyperkalemic activities of Ketorolac.
Tenoxicam Potassium carbonate may increase the hyperkalemic activities of Tenoxicam.
Celecoxib Potassium carbonate may increase the hyperkalemic activities of Celecoxib.
Sotalol Potassium carbonate may increase the hyperkalemic activities of Sotalol.
Tolmetin Potassium carbonate may increase the hyperkalemic activities of Tolmetin.
Lercanidipine Potassium carbonate may increase the hyperkalemic activities of Lercanidipine.
Rofecoxib Potassium carbonate may increase the hyperkalemic activities of Rofecoxib.
Piroxicam Potassium carbonate may increase the hyperkalemic activities of Piroxicam.
Lamotrigine Potassium carbonate may increase the hyperkalemic activities of Lamotrigine.
Cinnarizine Potassium carbonate may increase the hyperkalemic activities of Cinnarizine.
Propranolol Potassium carbonate may increase the hyperkalemic activities of Propranolol.
Fenoprofen Potassium carbonate may increase the hyperkalemic activities of Fenoprofen.
Valdecoxib Potassium carbonate may increase the hyperkalemic activities of Valdecoxib.
Diclofenac Potassium carbonate may increase the hyperkalemic activities of Diclofenac.
Ethosuximide Potassium carbonate may increase the hyperkalemic activities of Ethosuximide.
Labetalol Potassium carbonate may increase the hyperkalemic activities of Labetalol.
Sulindac Potassium carbonate may increase the hyperkalemic activities of Sulindac.
Bisoprolol Potassium carbonate may increase the hyperkalemic activities of Bisoprolol.
Nicardipine Potassium carbonate may increase the hyperkalemic activities of Nicardipine.
Magnesium sulfate Potassium carbonate may increase the hyperkalemic activities of Magnesium sulfate.
Nitrofurantoin Potassium carbonate may increase the hyperkalemic activities of Nitrofurantoin.
Flurbiprofen Potassium carbonate may increase the hyperkalemic activities of Flurbiprofen.
Pentamidine Potassium carbonate may increase the hyperkalemic activities of Pentamidine.
Mannitol Potassium carbonate may increase the hyperkalemic activities of Mannitol.
Etodolac Potassium carbonate may increase the hyperkalemic activities of Etodolac.
Potassium chloride Potassium carbonate may increase the hyperkalemic activities of Potassium chloride.
Mefenamic acid Potassium carbonate may increase the hyperkalemic activities of Mefenamic acid.
Naproxen Potassium carbonate may increase the hyperkalemic activities of Naproxen.
Sulfasalazine Potassium carbonate may increase the hyperkalemic activities of Sulfasalazine.
Phenylbutazone Potassium carbonate may increase the hyperkalemic activities of Phenylbutazone.
Meloxicam Potassium carbonate may increase the hyperkalemic activities of Meloxicam.
Carprofen Potassium carbonate may increase the hyperkalemic activities of Carprofen.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 19 • International brands: 1
Produk
  • Buffered Vitamin C Powder With Ca Mg and K
    Powder • - • Oral • Canada • OTC • Approved
  • Cleaning-S
    Liquid • 0.1 g/100mL • Topical • US • OTC
  • Face-body-S
    Liquid • 0.1 g/100mL • Topical • US • OTC
  • Food-S
    Liquid • 0.1 g/100mL • Oral; Topical • US • OTC
  • Greenfish, Body-S
    Liquid • 0.001 1/80mL • Topical • US • OTC
  • Greenfish, Cleaning-S
    Liquid • 0.001 1/450mL • Topical • US • OTC
  • Greenfish, Food-S
    Liquid • 0.001 1/450mL • Topical • US • OTC
  • Moonstar Face and Body Mist
    Spray • 0.08 g/80mL • Topical • US • OTC
Menampilkan 8 dari 19 produk.
International Brands
  • Racol

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul